What Researchers Did
This prospective cohort study evaluated the effects of hyperbaric oxygen treatment (HBOT) on patient-perceived symptoms of late radiation-induced cystitis and proctitis following pelvic cancer radiation therapy.
What They Found
HBOT successfully alleviated symptoms in 76% of patients with radiation cystitis, 89% with radiation proctitis, and 88% with combined conditions. Symptom reduction was significant, with urinary domain scores increasing from 50±16 to 66±20 (P<.001) and bowel domain scores from 48±18 to 68±18 (P<.001).
What This Means for Canadian Patients
Canadian patients experiencing late radiation-induced cystitis or proctitis after pelvic cancer treatment may find hyperbaric oxygen therapy to be an effective option for symptom relief. This treatment could significantly improve their quality of life by reducing urinary and bowel discomfort.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A limitation of this study is its relatively small sample size of 39 patients.